Glioblastoma Clinical Trials in Anaheim, CA

Glioblastoma Clinical Trials in Anaheim, CA

View the best 10 glioblastoma medical studies in Anaheim, California. Access promising new therapies by applying to a Anaheim-based Glioblastoma clinical trial.

Trials in Anaheim, California

Here are the top 10 medical studies for glioblastoma in Anaheim, California

Image of Hoag Memorial Hospital Presbyterian in Newport Beach, United States.

Bevacizumab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing the safety and effectiveness of a combination treatment for subjects with recurrent or progressive GBM using N-803, PD-L1 t-haNK, and Bevacizumab.
Image of Barrow Neurological Institute in Phoenix, United States.

Berubicin +1 More

Anthracenedione

Recruiting1 awardPhase 2
This trial will compare the effect of two cancer drugs, berubicin and lomustine, on overall survival in patients with glioblastoma multiforme (GBM) who have failed standard first line therapy. A futility analysis will be performed after approximately 30-50% of planned patients have completed the primary endpoint at 6 months.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Photon Beam Radiation Therapy +2 More

Radiation Therapy

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Children's Hospital of Alabama in Birmingham, United States.

Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial studies how well dabrafenib and trametinib work after radiation therapy in children and young adults with a specific type of brain tumor. These drugs help stop tumor growth by blocking signals that tell the cells to multiply. Dabrafenib has been developed and tested extensively for a specific type of skin cancer, showing effectiveness both alone and when used with trametinib.
Image of START Midwest, LLC in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.
Image of University of Maryland, Baltimore & The University of Maryland Medical System in Baltimore, United States.

Exablate Model 4000

Focused Ultrasound

Recruiting1 award
This trial aims to test the safety and effectiveness of using the Exablate device to temporarily open the blood-brain barrier in patients with suspected Glioblastoma. By doing this, doctors can collect fluid from the brain to check for cancer cells. The study will take place at up to 25 centers in the US.
Image of City of Hope Comprehensive Cancer Center LAO in Duarte, United States.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Image of City of Hope Medical Center in Duarte, United States.

CHM-1101 CAR-T cells

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial tests a new cancer treatment (CHM-1101) for glioblastoma to see if it is safe & effective.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.